 Ann-Christine Nyquist
Concepts (240)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Influenza, Human | 13 | 2024 | 543 | 2.060 |
Why?
| | Respiratory Tract Infections | 8 | 2021 | 319 | 1.200 |
Why?
| | Cross Infection | 7 | 2020 | 194 | 0.990 |
Why?
| | Infection Control | 4 | 2023 | 132 | 0.790 |
Why?
| | Surgical Wound Infection | 6 | 2023 | 246 | 0.770 |
Why?
| | Health Personnel | 9 | 2022 | 569 | 0.700 |
Why?
| | Bacteremia | 6 | 2019 | 160 | 0.530 |
Why?
| | Influenza Vaccines | 4 | 2024 | 497 | 0.510 |
Why?
| | Virus Diseases | 2 | 2016 | 195 | 0.510 |
Why?
| | Respiratory Protective Devices | 3 | 2021 | 11 | 0.490 |
Why?
| | Population Surveillance | 4 | 2020 | 385 | 0.430 |
Why?
| | Disease Outbreaks | 6 | 2020 | 305 | 0.430 |
Why?
| | Disaster Planning | 3 | 2020 | 74 | 0.400 |
Why?
| | Hospitals, Pediatric | 5 | 2019 | 478 | 0.400 |
Why?
| | Vaccination | 6 | 2024 | 1202 | 0.380 |
Why?
| | Influenza A virus | 3 | 2014 | 90 | 0.380 |
Why?
| | Influenza B virus | 2 | 2009 | 34 | 0.370 |
Why?
| | Chemical Terrorism | 2 | 2020 | 5 | 0.350 |
Why?
| | Anti-Bacterial Agents | 4 | 2020 | 1471 | 0.340 |
Why?
| | Bioterrorism | 2 | 2020 | 19 | 0.340 |
Why?
| | Masks | 3 | 2021 | 46 | 0.330 |
Why?
| | Disease Notification | 1 | 2009 | 12 | 0.330 |
Why?
| | Health Care Surveys | 1 | 2010 | 541 | 0.300 |
Why?
| | Delivery of Health Care | 9 | 2022 | 828 | 0.290 |
Why?
| | Equipment Contamination | 3 | 2019 | 54 | 0.280 |
Why?
| | Mycoplasma hominis | 1 | 2006 | 4 | 0.270 |
Why?
| | Endocarditis, Bacterial | 1 | 2006 | 37 | 0.260 |
Why?
| | Enterovirus Infections | 3 | 2015 | 160 | 0.260 |
Why?
| | Medication Systems, Hospital | 1 | 2005 | 8 | 0.260 |
Why?
| | Forms and Records Control | 1 | 2005 | 21 | 0.250 |
Why?
| | Drug Utilization Review | 1 | 2005 | 56 | 0.250 |
Why?
| | Electronics | 1 | 2005 | 66 | 0.250 |
Why?
| | Antibiotic Prophylaxis | 1 | 2005 | 95 | 0.240 |
Why?
| | Pandemics | 2 | 2022 | 1310 | 0.230 |
Why?
| | Humans | 45 | 2024 | 114045 | 0.230 |
Why?
| | Surgical Procedures, Operative | 1 | 2005 | 206 | 0.210 |
Why?
| | Seasons | 5 | 2024 | 440 | 0.210 |
Why?
| | Child | 18 | 2022 | 18401 | 0.210 |
Why?
| | Coronavirus OC43, Human | 1 | 2021 | 5 | 0.200 |
Why?
| | Tuberculosis, Spinal | 1 | 2001 | 6 | 0.200 |
Why?
| | Personal Protective Equipment | 1 | 2022 | 50 | 0.190 |
Why?
| | Hospitalization | 2 | 2015 | 1762 | 0.190 |
Why?
| | Orthomyxoviridae Infections | 1 | 2022 | 54 | 0.190 |
Why?
| | Guideline Adherence | 1 | 2005 | 489 | 0.190 |
Why?
| | Thoracic Vertebrae | 1 | 2001 | 68 | 0.190 |
Why?
| | Colorado | 8 | 2020 | 4090 | 0.190 |
Why?
| | Physician's Role | 2 | 2020 | 192 | 0.190 |
Why?
| | Virology | 2 | 2011 | 19 | 0.190 |
Why?
| | Meningitis, Viral | 2 | 2011 | 21 | 0.190 |
Why?
| | Streptococcus pneumoniae | 3 | 2010 | 133 | 0.180 |
Why?
| | Influenza A Virus, H1N1 Subtype | 1 | 2022 | 138 | 0.180 |
Why?
| | Enterovirus | 2 | 2011 | 72 | 0.180 |
Why?
| | Practice Patterns, Physicians' | 2 | 1999 | 1175 | 0.170 |
Why?
| | Clostridium Infections | 1 | 2020 | 54 | 0.170 |
Why?
| | Civil Defense | 1 | 2020 | 17 | 0.170 |
Why?
| | Heart Defects, Congenital | 1 | 2006 | 683 | 0.170 |
Why?
| | Viruses | 1 | 2021 | 94 | 0.170 |
Why?
| | Serratia Infections | 1 | 2019 | 6 | 0.170 |
Why?
| | Serratia marcescens | 1 | 2019 | 12 | 0.170 |
Why?
| | Infectious Disease Transmission, Patient-to-Professional | 1 | 2019 | 19 | 0.160 |
Why?
| | Child, Preschool | 11 | 2019 | 9114 | 0.160 |
Why?
| | Rotavirus Infections | 1 | 1999 | 50 | 0.160 |
Why?
| | Syringes | 1 | 2019 | 41 | 0.160 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 2 | 2011 | 924 | 0.160 |
Why?
| | Antimicrobial Stewardship | 1 | 2020 | 92 | 0.160 |
Why?
| | United States | 13 | 2023 | 12137 | 0.150 |
Why?
| | Pediatricians | 1 | 2020 | 122 | 0.150 |
Why?
| | Electronic Health Records | 2 | 2018 | 799 | 0.150 |
Why?
| | Common Cold | 1 | 1998 | 12 | 0.150 |
Why?
| | Mandatory Programs | 1 | 2018 | 14 | 0.150 |
Why?
| | Communicable Diseases | 1 | 2020 | 127 | 0.150 |
Why?
| | Bronchitis | 1 | 1998 | 35 | 0.150 |
Why?
| | Hospitals | 3 | 2023 | 581 | 0.140 |
Why?
| | Drug Utilization | 1 | 1998 | 164 | 0.140 |
Why?
| | Mutation | 1 | 2007 | 3338 | 0.140 |
Why?
| | Fatigue | 1 | 2018 | 294 | 0.140 |
Why?
| | Infant, Newborn | 5 | 2015 | 5038 | 0.130 |
Why?
| | Catheter-Related Infections | 1 | 2016 | 61 | 0.130 |
Why?
| | Spinal Fusion | 2 | 2013 | 199 | 0.130 |
Why?
| | Occupational Diseases | 1 | 2016 | 128 | 0.120 |
Why?
| | Adult | 10 | 2020 | 30375 | 0.120 |
Why?
| | Herpesvirus 2, Human | 1 | 1994 | 27 | 0.110 |
Why?
| | Laryngeal Diseases | 1 | 1994 | 21 | 0.110 |
Why?
| | Enterovirus D, Human | 1 | 2015 | 72 | 0.110 |
Why?
| | Gram-Positive Bacterial Infections | 2 | 2012 | 61 | 0.110 |
Why?
| | Acyclovir | 1 | 1994 | 100 | 0.110 |
Why?
| | Herpes Simplex | 1 | 1994 | 87 | 0.110 |
Why?
| | Pertussis Vaccine | 1 | 2012 | 21 | 0.100 |
Why?
| | Adolescent | 9 | 2015 | 17800 | 0.100 |
Why?
| | Whooping Cough | 1 | 2012 | 48 | 0.100 |
Why?
| | Bacillus cereus | 1 | 2012 | 5 | 0.100 |
Why?
| | Shock | 1 | 2013 | 83 | 0.100 |
Why?
| | Guidelines as Topic | 1 | 2014 | 241 | 0.100 |
Why?
| | Infant | 8 | 2015 | 7943 | 0.100 |
Why?
| | Comorbidity | 1 | 2016 | 1447 | 0.100 |
Why?
| | Consensus | 3 | 2024 | 532 | 0.100 |
Why?
| | Decision Making | 1 | 2018 | 760 | 0.100 |
Why?
| | Quality Assurance, Health Care | 1 | 2014 | 308 | 0.100 |
Why?
| | Spinal Diseases | 1 | 2012 | 39 | 0.100 |
Why?
| | Age Distribution | 2 | 2010 | 341 | 0.100 |
Why?
| | Shock, Septic | 1 | 2013 | 185 | 0.100 |
Why?
| | Female | 17 | 2019 | 59324 | 0.090 |
Why?
| | Male | 15 | 2019 | 55396 | 0.090 |
Why?
| | Software | 1 | 2014 | 526 | 0.090 |
Why?
| | Ethics, Clinical | 1 | 2010 | 7 | 0.090 |
Why?
| | Young Adult | 5 | 2015 | 10444 | 0.090 |
Why?
| | Online Systems | 1 | 2010 | 23 | 0.090 |
Why?
| | Health Planning | 1 | 2010 | 46 | 0.090 |
Why?
| | Ethics, Medical | 1 | 2010 | 69 | 0.080 |
Why?
| | Decontamination | 2 | 2020 | 23 | 0.080 |
Why?
| | Middle Aged | 7 | 2019 | 26605 | 0.080 |
Why?
| | Orthopedic Procedures | 1 | 2012 | 206 | 0.080 |
Why?
| | Laboratories, Hospital | 1 | 2009 | 14 | 0.080 |
Why?
| | Chlamydia Infections | 1 | 2010 | 63 | 0.080 |
Why?
| | Pneumococcal Infections | 1 | 2010 | 91 | 0.080 |
Why?
| | Gonorrhea | 1 | 2010 | 54 | 0.080 |
Why?
| | Workload | 1 | 2010 | 131 | 0.080 |
Why?
| | Poison Control Centers | 2 | 2020 | 84 | 0.080 |
Why?
| | Epoprostenol | 1 | 2009 | 133 | 0.080 |
Why?
| | Clinical Laboratory Techniques | 1 | 2009 | 86 | 0.080 |
Why?
| | Catheterization, Central Venous | 1 | 2009 | 83 | 0.080 |
Why?
| | Ambulatory Care Facilities | 1 | 2010 | 212 | 0.070 |
Why?
| | Ethanol | 1 | 2012 | 534 | 0.070 |
Why?
| | Genetic Drift | 1 | 2007 | 6 | 0.070 |
Why?
| | Prescriptions | 1 | 2008 | 60 | 0.070 |
Why?
| | Incidence | 4 | 2019 | 2314 | 0.070 |
Why?
| | Patient Care Team | 1 | 2012 | 517 | 0.070 |
Why?
| | Respiratory System | 1 | 2007 | 137 | 0.070 |
Why?
| | Drug Resistance, Microbial | 2 | 1998 | 66 | 0.070 |
Why?
| | Sexual Behavior | 1 | 2010 | 434 | 0.060 |
Why?
| | Antihypertensive Agents | 1 | 2009 | 428 | 0.060 |
Why?
| | Practice Guidelines as Topic | 1 | 2013 | 1381 | 0.060 |
Why?
| | Internet | 1 | 2010 | 591 | 0.060 |
Why?
| | Aged, 80 and over | 3 | 2015 | 6306 | 0.060 |
Why?
| | Risk Factors | 5 | 2021 | 8614 | 0.060 |
Why?
| | Medical Audit | 1 | 2005 | 75 | 0.060 |
Why?
| | Pneumococcal Vaccines | 1 | 2006 | 131 | 0.060 |
Why?
| | Delphi Technique | 2 | 2016 | 157 | 0.060 |
Why?
| | Ambulatory Care | 2 | 2019 | 479 | 0.060 |
Why?
| | Needs Assessment | 2 | 2020 | 315 | 0.060 |
Why?
| | Logistic Models | 3 | 2010 | 1829 | 0.050 |
Why?
| | Attitude of Health Personnel | 1 | 2010 | 970 | 0.050 |
Why?
| | Europe | 1 | 2024 | 332 | 0.050 |
Why?
| | Immunization Programs | 2 | 2018 | 204 | 0.050 |
Why?
| | Hemagglutination Inhibition Tests | 1 | 2022 | 37 | 0.050 |
Why?
| | Surveys and Questionnaires | 2 | 2010 | 4595 | 0.050 |
Why?
| | Influenza A Virus, H3N2 Subtype | 1 | 2022 | 40 | 0.050 |
Why?
| | Patient Satisfaction | 2 | 2010 | 571 | 0.050 |
Why?
| | Pneumonia | 1 | 2006 | 563 | 0.050 |
Why?
| | Aged | 4 | 2015 | 18969 | 0.050 |
Why?
| | Pediatrics | 2 | 2020 | 982 | 0.050 |
Why?
| | Multivariate Analysis | 2 | 2010 | 1422 | 0.050 |
Why?
| | Nerve Agents | 1 | 2020 | 4 | 0.040 |
Why?
| | Ricin | 1 | 2020 | 8 | 0.040 |
Why?
| | Containment of Biohazards | 1 | 2020 | 11 | 0.040 |
Why?
| | Surge Capacity | 1 | 2020 | 7 | 0.040 |
Why?
| | Smallpox | 1 | 2020 | 7 | 0.040 |
Why?
| | Government Agencies | 1 | 2020 | 15 | 0.040 |
Why?
| | Asphyxia | 1 | 2020 | 21 | 0.040 |
Why?
| | Biological Factors | 1 | 2020 | 35 | 0.040 |
Why?
| | Government Regulation | 1 | 2020 | 46 | 0.040 |
Why?
| | Irritants | 1 | 2020 | 41 | 0.040 |
Why?
| | Health Care Costs | 2 | 2013 | 381 | 0.040 |
Why?
| | Attitude | 1 | 2021 | 228 | 0.040 |
Why?
| | Gait | 1 | 2001 | 250 | 0.040 |
Why?
| | Antibodies, Viral | 1 | 2022 | 520 | 0.040 |
Why?
| | Hypertension, Pulmonary | 1 | 2009 | 1736 | 0.040 |
Why?
| | Viral Vaccines | 1 | 1999 | 88 | 0.040 |
Why?
| | Outpatients | 1 | 2021 | 325 | 0.040 |
Why?
| | Heparin | 1 | 2019 | 225 | 0.040 |
Why?
| | Health Services Misuse | 1 | 1998 | 36 | 0.040 |
Why?
| | Rhinitis | 1 | 1999 | 128 | 0.040 |
Why?
| | Histocompatibility Antigens Class II | 1 | 1999 | 350 | 0.040 |
Why?
| | Airway Obstruction | 1 | 2020 | 160 | 0.040 |
Why?
| | Absenteeism | 1 | 2018 | 40 | 0.040 |
Why?
| | Research | 1 | 2020 | 389 | 0.040 |
Why?
| | Efficiency, Organizational | 1 | 2018 | 126 | 0.030 |
Why?
| | Occupational Exposure | 1 | 2019 | 255 | 0.030 |
Why?
| | Nasopharyngeal Diseases | 1 | 1996 | 5 | 0.030 |
Why?
| | Lung Abscess | 1 | 1996 | 6 | 0.030 |
Why?
| | Environmental Exposure | 1 | 2020 | 372 | 0.030 |
Why?
| | Streptococcus pyogenes | 1 | 1996 | 30 | 0.030 |
Why?
| | Illinois | 1 | 2015 | 37 | 0.030 |
Why?
| | Missouri | 1 | 2015 | 61 | 0.030 |
Why?
| | Maryland | 1 | 2014 | 37 | 0.030 |
Why?
| | Health Policy | 1 | 2018 | 330 | 0.030 |
Why?
| | Respiratory Sounds | 1 | 2015 | 109 | 0.030 |
Why?
| | Cough | 1 | 2015 | 107 | 0.030 |
Why?
| | Mental Health | 1 | 2020 | 559 | 0.030 |
Why?
| | Workplace | 1 | 2016 | 221 | 0.030 |
Why?
| | Foscarnet | 1 | 1994 | 18 | 0.030 |
Why?
| | Streptococcal Infections | 1 | 1996 | 127 | 0.030 |
Why?
| | Prevalence | 2 | 2010 | 2247 | 0.030 |
Why?
| | Prospective Studies | 2 | 2016 | 6195 | 0.030 |
Why?
| | Program Evaluation | 2 | 2010 | 820 | 0.030 |
Why?
| | Fever | 1 | 2015 | 280 | 0.030 |
Why?
| | Retrospective Studies | 2 | 2012 | 12521 | 0.030 |
Why?
| | Dyspnea | 1 | 2015 | 212 | 0.030 |
Why?
| | Public Health Surveillance | 1 | 2013 | 61 | 0.030 |
Why?
| | Health Surveys | 1 | 2014 | 441 | 0.030 |
Why?
| | Algorithms | 1 | 2020 | 1469 | 0.030 |
Why?
| | Follow-Up Studies | 2 | 2012 | 4392 | 0.030 |
Why?
| | Product Recalls and Withdrawals | 1 | 2012 | 2 | 0.030 |
Why?
| | Molecular Typing | 1 | 2012 | 18 | 0.030 |
Why?
| | Respiration, Artificial | 1 | 2015 | 528 | 0.020 |
Why?
| | Case-Control Studies | 2 | 2010 | 3003 | 0.020 |
Why?
| | Critical Care | 1 | 2015 | 472 | 0.020 |
Why?
| | Elective Surgical Procedures | 1 | 2012 | 150 | 0.020 |
Why?
| | Scoliosis | 1 | 2013 | 178 | 0.020 |
Why?
| | Cerebrospinal Fluid | 1 | 2010 | 90 | 0.020 |
Why?
| | Contact Tracing | 1 | 2010 | 14 | 0.020 |
Why?
| | San Francisco | 1 | 2010 | 54 | 0.020 |
Why?
| | Vaccines, Conjugate | 1 | 2010 | 59 | 0.020 |
Why?
| | Primary Health Care | 1 | 2020 | 1502 | 0.020 |
Why?
| | Lung Diseases | 1 | 1996 | 690 | 0.020 |
Why?
| | Diagnosis, Differential | 1 | 2013 | 1331 | 0.020 |
Why?
| | Gram-Negative Bacterial Infections | 1 | 2009 | 36 | 0.020 |
Why?
| | Sex Distribution | 1 | 2010 | 336 | 0.020 |
Why?
| | Gram-Positive Bacteria | 1 | 2009 | 45 | 0.020 |
Why?
| | Gram-Negative Bacteria | 1 | 2009 | 66 | 0.020 |
Why?
| | Catheters, Indwelling | 1 | 2009 | 74 | 0.020 |
Why?
| | Reference Values | 1 | 2010 | 739 | 0.020 |
Why?
| | Infusions, Intravenous | 1 | 2009 | 370 | 0.020 |
Why?
| | Sex Factors | 1 | 2013 | 1706 | 0.020 |
Why?
| | Risk Reduction Behavior | 1 | 2009 | 200 | 0.020 |
Why?
| | Urban Population | 1 | 2010 | 396 | 0.020 |
Why?
| | Length of Stay | 1 | 2012 | 957 | 0.020 |
Why?
| | RNA, Viral | 1 | 2010 | 565 | 0.020 |
Why?
| | Serotyping | 1 | 2006 | 28 | 0.020 |
Why?
| | Age Factors | 1 | 2013 | 2885 | 0.020 |
Why?
| | Sensitivity and Specificity | 1 | 2010 | 1690 | 0.020 |
Why?
| | Socioeconomic Factors | 1 | 2010 | 1080 | 0.020 |
Why?
| | Immunization Schedule | 1 | 2006 | 183 | 0.020 |
Why?
| | Asthma | 1 | 2015 | 2021 | 0.010 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2010 | 1168 | 0.010 |
Why?
| | Time Factors | 1 | 2010 | 6077 | 0.010 |
Why?
| | Gallium Radioisotopes | 1 | 1996 | 12 | 0.010 |
Why?
| | Retropharyngeal Abscess | 1 | 1996 | 8 | 0.010 |
Why?
| | Radionuclide Imaging | 1 | 1996 | 115 | 0.010 |
Why?
| | Tomography, X-Ray Computed | 1 | 1996 | 2272 | 0.000 |
Why?
|
|
Nyquist's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|